Vivani Medical, Inc. VANI
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus
Chart by TradingView
1/9
Piotroski F — financial health
-14.41
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $0 | -$26.6M | — | -$25.5M | $15.7M |
| 2024 | $0 | -$23.5M | — | -$21.3M | $17.6M |
| 2023 | — | -$25.7M | — | -$24.6M | $20.8M |
| 2022 | — | -$13.9M | — | -$19.1M | $44.3M |
| 2021 | — | -$12.8M | $130,000 | -$11.5M | $2.5M |
| 2020 | — | -$14.9M | $500,000 | -$17.2M | $1.9M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Williams Gregg | director | 2026-06-15 | Buy | 1,587,301 | $1.26 |
| Williams Gregg | director | 2026-05-15 | Buy | 1,587,301 | $1.26 |
| Williams Gregg | director | 2026-04-15 | Buy | 1,587,301 | $1.26 |
| Williams Gregg | director | 2026-03-15 | Buy | 1,310,680 | $1.03 |
| Williams Gregg | director | 2026-03-15 | Buy | 264,551 | $1.26 |
| Williams Gregg | director | 2026-02-15 | Buy | 1,601,941 | $1.03 |
| Williams Gregg | director | 2026-02-15 | Buy | 264,551 | $1.26 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -14.41 (distress)
- Working capital / assets 0.287
- Retained earnings / assets -3.771
- EBIT / assets -0.7
- Equity / liabilities 0.665
Source: SEC EDGAR filings · CIK 0001266806 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.